Global Smart Biopsy Devices Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers

31 Oct, 2023

The global smart biopsy devices market is expected to grow from $2.54 billion in 2022 to $2.73 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The smart biopsy devices market is expected to reach $3.53 billion in 2027 at a CAGR of 6.6%.

Global Smart Biopsy Devices Market Key Driver

The increasing incidence of cancer is anticipated to drive the expansion of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can emerge in almost any body organ or tissue when abnormal cells undergo uncontrolled proliferation, breach their usual confines, and either spread to other organs or infiltrate neighboring body parts. The growing number of cancer cases has elevated the demand for accurate and targeted tissue samples. Consequently, this has stimulated the development and progression of intelligent biopsy tools equipped with improved molecular, imaging, and precision capabilities, aiding in the diagnosis and planning of treatment.

Get a sample of the global smart biopsy devices market report

Global Smart Biopsy Devices Market Segments

The global smart biopsy devices market is segmented:
1) By Product: Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
5) By Geography: The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global smart biopsy devices market.

Major Smart Biopsy Devices Industry Players

  • Cardinal Health Inc
  • General Electric Company
  • Medtronic Plc
  • Danaher Corporation
  • Canon Medical Systems Corporation
  • Toshiba Corporation
  • Siemens Healthineers
  • FUJIFILM Holdings Corporation
  • Koninklijke Philips N.V.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Get the full global smart biopsy devices market report

    Smart Biopsy Devices Market Overview

    Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features like image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.

    Smart Biopsy Devices Global Market Report 2023 provides data on the global smart biopsy devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The smart biopsy devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.